QinCRyanMD

PubMed

• Trends in Erythropoiesis-stimulating agent use and blood transfusions for chemotherapy-induced anemia throughout FDA's risk evaluation and mitigation strategy lifecycle.
  Amarilys Vega, Rongmei Zhang, Hui-Lee Wong, Michael Wernecke, Michael Alexander, Yuhui Feng, An-Chi Lo, Bradley Lufkin, Qin Ryan, Rima Izem, Thomas E. MaCurdy, Jeffrey...> ;Pharmacoepidemiology and Drug Safety. 2021 Feb 22
• 29 citations
  Association Between Changes in CMS Reimbursement Policy and Drug Labels for Erythrocyte-Stimulating Agents With Outcomes for Older Patients Undergoing Hemodialysis Cov...
  Cunlin Wang, Robert C. Kane, Mark Levenson, Jeffrey A. Kelman, Michael Wernecke, Joo-Yeon Lee, Steven Kozlowski, Carmen Dekmezian, Zhiwei Zhang, Aliza Thompson, Kimber...> ;JAMA Internal Medicine. 2016 Dec 1
• 142 citations
  Comparative Risk of Anaphylactic Reactions Associated With Intravenous Iron Products
  Cunlin Wang, David J. Graham, Robert C. Kane, Diqiong Xie, Michael Wernecke, Mark Levenson, Thomas E. MaCurdy, Monica Houstoun, Qin Ryan, Sarah Wong, Katrina Mott, Tin...> ;JAMA. 2015 Nov 17
• 14 citations
  A phase I and pharmacokinetic study of oral perifosine with different loading schedules in patients with refractory neoplasms
  William D. Figg, Manish Monga, Donna Headlee, Avni A. Shah, Cindy H. Chau, Cody J. Peer, Richard Messman, Yusri A. Elsayed, Anthony J. Murgo, Giovanni Melillo, Qin C. ...> ;Cancer Chemotherapy and Pharmacology. 2014 Sep 3
• 201 citations
  FDA drug approval summary: lapatinib in combination with capecitabine for previously treated metastatic breast cancer that overexpresses HER-2.
  Qin Ryan, Amna Ibrahim, Martin H. Cohen, John R. Johnson, Chia-Wen Ko, Rajeshwari Sridhara, Robert Justice, Richard Pazdur> ;The Oncologist. 2008 Oct 1
• 101 citations
  Phase I trial of MS-275, a histone deacetylase inhibitor, administered weekly in refractory solid tumors and lymphoid malignancies.
  Shivaani Kummar, Martin Gutierrez, Erin R. Gardner, Erin E. Donovan, Kyunghwa Hwang, Eun Joo Chung, Min-Jung Lee, Kim Maynard, Mikhail Kalnitskiy, Alice P. Chen, Giova...> ;Clinical Cancer Research. 2007 Sep 15
• An analysis of deficiencies identified during investigational new drug (IND) application reviews by the Division of Drug Oncology Products (DDOP) of the US FDA.
  Mann BS, Kane R, Brave M, Ryan Q, Hazarika M, Rock E, Senderowicz A, Dagher R, Johnson J, Justice R, Pazdur R> ;J. Clin. Oncol.. 2006-06-20
• 18 citations
  Factors affecting the pharmacokinetic profile of MS-275, a novel histone deacetylase inhibitor, in patients with cancer
  Milin Acharya, Judith E. Karp, Edward A. Sausville, Kyunghwa Hwang, Qin C. Ryan, Ivana Gojo, Jűrgen Venitz, William D. Figg, Alex Sparreboom> ;Investigational New Drugs. 2006 Mar 31
• 21 citations
  Histone Deacetylase Inhibitor Pharmacodynamic Analysis by Multiparameter Flow Cytometry
  Eun Joo Chung, Sunmin Lee, Edward A. Sausville, Qin C. Ryan, Judith E. Karp, Ivana Gojo, William G. Telford, Min-Jung Lee, Hye Sik Kong, Jane B. Trepel> ;Annals of Clinical and Laboratory Science. 2005 Sep 21
• 331 citations
  Phase I and Pharmacokinetic Study of MS-275, a Histone Deacetylase Inhibitor, in Patients With Advanced and Refractory Solid Tumors or Lymphoma
  Qin C. Ryan, Donna Headlee, Milin Acharya, Alex Sparreboom, Jane B. Trepel, Joseph Z. Ye, William D. Figg, Kyunghwa Hwang, Eun Joo Chung, Anthony J. Murgo, Giovanni Me...> ;Journal of Clinical Oncology. 2005 Jun 10
• Phase I pharmacokinetic-pharmacodynamic trial of weekly MS-275, an oral histone deacetylase inhibitor.
  Donovan EA, Ryan Q, Acharya M, Chung E, Trepel J, Maynard K, Sausville E, Murgo A, Melillo G, Conley B> ;J. Clin. Oncol.. 2005-06-01
• 13 citations
  Fluorodeoxyglucose positron emission tomography in the presence of cardiac metastases.
  John D. Nguyen, Jorge A. Carrasquillo, Richard F. Little, Qin C. Ryan, Wyndham H. Wilson, Clara C. Chen> ;Clinical Nuclear Medicine. 2003 Dec 1
• 7 citations
  Extension of lifespan of human T lymphocytes by transfection with SV40 large T antigen
  Qin C. Ryan, I.Michael Goonewardene, Donna M. Murasko> ;Experimental Cell Research. 1992 Apr 1
• 5 citations
  Altered macrophage antigen-presenting cell function following Friend leukemia virus infection.
  Sylvia M. Jones, Marlena A. Moors, Qin Ryan, Karen K. Klyczek, Kenneth J. Blank> ;Viral Immunology. 1992 Jan 1
• 5 citations
  Maintenance of normal T lymphocyte function after transfection with SV40 large T
  Q C Ryan, I M Goonewardene, Donna M. Murasko> ;Cellular Immunology. 1993 Jun 1
• Join now to see all